Ivatero 5 mg /7,5 mg FC tablet
PDF Leaflet Revision Date: 10 June 2025
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of chronic stable angina pectoris and chronic heart failure.
Dosage (summary)
5 mg twice daily, may increase to 7.5 mg if tolerated.
Special Populations
- Elderly
- Renal impairment
- Hepatic impairment
Pregnancy & Breastfeeding
Contraindicated in pregnancy and lactation due to teratogenic effects.
Key Drug Interactions
- Strong CYP3A4 inhibitors
- Moderate CYP3A4 inhibitors
- QT-prolonging medicines
Contraindications
- Severe hypotension
- 3rd degree AV block
- Pacemaker dependence
- Resting heart rate < 70 bpm
Common side effects
- Bradycardia
- Phosphenes
- Headache
- Dizziness
Counselling Points
- Take with food
- Monitor for visual disturbances
- Report symptoms of bradycardia
Serious warnings
- Risk of atrial fibrillation
- Monitor heart rate
- Discontinue if no improvement in angina
Important Disclaimer
The Ivatero 5 mg /7,5 mg FC tablet professional information leaflet below is the property of Hetero Drugs South Africa and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
